Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Revenues $ 50,000 $ 0
Operating expenses 2,938,000 2,103,000
Research and development expenses 243,000 279,000
Loss before other income (expense) (3,131,000) (2,382,000)
Other income 0 2,000
Interest and financing expense (1,704,000) (1,617,000)
Loss on disposition of equipment 0 (3,000)
Net Loss $ (4,835,000) $ (4,000,000)
Net loss per common share, basic and diluted $ (0.02) $ (0.02)
Weighted average common shares outstanding, basic and diluted 217,790,405 192,831,810